OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PLYP58

Polyplex Corp Ltd

Commodity ChemicalsVerified

Polyplex Corp Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.23, indicating a low reliance on debt financing. The company's liquidity position is reflected in a current ratio of 2.78, suggesting it can cover its short-term obligations comfortably. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Polyplex's return on equity (ROE) is 5.56%, and its return on assets (ROA) is 2.62%. These figures are below the typical thresholds for high-performing companies in the Commodity Chemicals industry, indicating that the company is not generating strong returns relative to its equity and asset base. The company's revenue is derived from a range of plastic film products, with no specific segment breakdown provided in the input data. However, the global distribution of its manufacturing plants in India, Thailand, Indonesia, Turkey, and the United States suggests a diversified geographic exposure. This diversification may help mitigate regional economic risks but also introduces complexity in managing operations across multiple jurisdictions. Polyplex's growth trajectory is not explicitly detailed in the input data, but the company's capital expenditure of -5.03 billion INR indicates a net outflow, which may suggest a period of investment or expansion. The absence of a clear revenue growth rate or outlook makes it difficult to assess the company's future performance with certainty. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the fact that the number of shares outstanding is the same for both basic and diluted shares, indicating no imminent threat of share dilution. However, the negative net cash position after debt is a concern for liquidity. Recent events and filings are not detailed in the input data, so no specific recent developments can be cited. The company's ESG controversies score of 100.0 is high, suggesting potential environmental, social, or governance issues that could impact its reputation and operational performance.

30-day price · PLYP+107.45 (+13.6%)
Low$758.75High$978.00Close$899.15As of17 May, 00:00 UTC
Profile
CompanyPolyplex Corp Ltd
TickerPLYP.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Polyplex Corporation Limited is engaged in the manufacturing of plastic films, including BOPET, BOPP, CPP, and PP/PE films, with products used in labels, printing, lamination, and packaging applications.

Classification. Polyplex is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Polyplex Corp Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.23, indicating a low reliance on debt financing. The company's liquidity position is reflected in a current ratio of 2.78, suggesting it can cover its short-term obligations comfortably. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Polyplex's return on equity (ROE) is 5.56%, and its return on assets (ROA) is 2.62%. These figures are below the typical thresholds for high-performing companies in the Commodity Chemicals industry, indicating that the company is not generating strong returns relative to its equity and asset base. The company's revenue is derived from a range of plastic film products, with no specific segment breakdown provided in the input data. However, the global distribution of its manufacturing plants in India, Thailand, Indonesia, Turkey, and the United States suggests a diversified geographic exposure. This diversification may help mitigate regional economic risks but also introduces complexity in managing operations across multiple jurisdictions. Polyplex's growth trajectory is not explicitly detailed in the input data, but the company's capital expenditure of -5.03 billion INR indicates a net outflow, which may suggest a period of investment or expansion. The absence of a clear revenue growth rate or outlook makes it difficult to assess the company's future performance with certainty. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's low dilution risk is supported by the fact that the number of shares outstanding is the same for both basic and diluted shares, indicating no imminent threat of share dilution. However, the negative net cash position after debt is a concern for liquidity. Recent events and filings are not detailed in the input data, so no specific recent developments can be cited. The company's ESG controversies score of 100.0 is high, suggesting potential environmental, social, or governance issues that could impact its reputation and operational performance.
Key takeaways
  • Polyplex Corp Ltd has a conservative capital structure with a low debt-to-equity ratio of 0.23.
  • The company's ROE of 5.56% and ROA of 2.62% are below typical thresholds for high-performing companies in the Commodity Chemicals industry.
  • The company's manufacturing operations are geographically diversified across India, Thailand, Indonesia, Turkey, and the United States.
  • The company's capital expenditure of -5.03 billion INR suggests a period of investment or expansion.
  • The company faces a medium liquidity risk and a low dilution risk.
  • The company's ESG controversies score of 100.0 indicates potential environmental, social, or governance issues.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$68.85B
Gross profit$19.09B
Operating income$3.99B
Net income$2.09B
R&D
SG&A
D&A
SBC
Operating cash flow$4.38B
CapEx-$5.03B
Free cash flow$1.23B
Total assets$79.98B
Total liabilities$42.35B
Total equity$37.63B
Cash & equivalents$2.80B
Long-term debt$8.82B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$37.63B
Net cash-$6.02B
Current ratio2.8
Debt/Equity0.2
ROA2.6%
ROE5.6%
Cash conversion2.1%
CapEx/Revenue-7.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricPLYPActivity
Op margin5.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin27.7%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity23.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar52.9
market data ESG social pillar51.4
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 16:16 UTC#dbe2fa06
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 16:18 UTCJob: 99d42961